Cargando…

AC‐1001 H3 CDR peptide induces apoptosis and signs of autophagy in vitro and exhibits antimetastatic activity in a syngeneic melanoma model

Antibody‐derived peptides modulate functions of the immune system and are a source of anti‐infective and antitumor substances. Recent studies have shown that they comprise amino acid sequences of immunoglobulin complementarity‐determining regions, but also fragments of constant regions. V(H) CDR3 of...

Descripción completa

Detalles Bibliográficos
Autores principales: Rabaça, Aline N., Arruda, Denise C., Figueiredo, Carlos R., Massaoka, Mariana H., Farias, Camyla F., Tada, Dayane B., Maia, Vera C., Silva Junior, Pedro I., Girola, Natalia, Real, Fernando, Mortara, Renato A., Polonelli, Luciano, Travassos, Luiz R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011487/
https://www.ncbi.nlm.nih.gov/pubmed/27642552
http://dx.doi.org/10.1002/2211-5463.12080
_version_ 1782451832733302784
author Rabaça, Aline N.
Arruda, Denise C.
Figueiredo, Carlos R.
Massaoka, Mariana H.
Farias, Camyla F.
Tada, Dayane B.
Maia, Vera C.
Silva Junior, Pedro I.
Girola, Natalia
Real, Fernando
Mortara, Renato A.
Polonelli, Luciano
Travassos, Luiz R.
author_facet Rabaça, Aline N.
Arruda, Denise C.
Figueiredo, Carlos R.
Massaoka, Mariana H.
Farias, Camyla F.
Tada, Dayane B.
Maia, Vera C.
Silva Junior, Pedro I.
Girola, Natalia
Real, Fernando
Mortara, Renato A.
Polonelli, Luciano
Travassos, Luiz R.
author_sort Rabaça, Aline N.
collection PubMed
description Antibody‐derived peptides modulate functions of the immune system and are a source of anti‐infective and antitumor substances. Recent studies have shown that they comprise amino acid sequences of immunoglobulin complementarity‐determining regions, but also fragments of constant regions. V(H) CDR3 of murine mAb AC‐1001 displays antimetastatic activities using B16F10‐Nex2 murine melanoma cells in a syngeneic model. The peptide was cytotoxic in vitro in murine and human melanoma cells inducing reactive oxygen species (ROS) and apoptosis by the intrinsic pathway. Signs of autophagy were also suggested by the increased expression of LC3/LC3II and Beclin 1 and by ultrastructural evidence. AC‐1001 H3 bound to both G‐ and F‐actin and inhibited tumor cell migration. These results are important evidence of the antitumor activity of Ig CDR‐derived peptides.
format Online
Article
Text
id pubmed-5011487
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-50114872016-09-16 AC‐1001 H3 CDR peptide induces apoptosis and signs of autophagy in vitro and exhibits antimetastatic activity in a syngeneic melanoma model Rabaça, Aline N. Arruda, Denise C. Figueiredo, Carlos R. Massaoka, Mariana H. Farias, Camyla F. Tada, Dayane B. Maia, Vera C. Silva Junior, Pedro I. Girola, Natalia Real, Fernando Mortara, Renato A. Polonelli, Luciano Travassos, Luiz R. FEBS Open Bio Research Articles Antibody‐derived peptides modulate functions of the immune system and are a source of anti‐infective and antitumor substances. Recent studies have shown that they comprise amino acid sequences of immunoglobulin complementarity‐determining regions, but also fragments of constant regions. V(H) CDR3 of murine mAb AC‐1001 displays antimetastatic activities using B16F10‐Nex2 murine melanoma cells in a syngeneic model. The peptide was cytotoxic in vitro in murine and human melanoma cells inducing reactive oxygen species (ROS) and apoptosis by the intrinsic pathway. Signs of autophagy were also suggested by the increased expression of LC3/LC3II and Beclin 1 and by ultrastructural evidence. AC‐1001 H3 bound to both G‐ and F‐actin and inhibited tumor cell migration. These results are important evidence of the antitumor activity of Ig CDR‐derived peptides. John Wiley and Sons Inc. 2016-07-15 /pmc/articles/PMC5011487/ /pubmed/27642552 http://dx.doi.org/10.1002/2211-5463.12080 Text en © 2016 The Authors. Published by FEBS Press and John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Rabaça, Aline N.
Arruda, Denise C.
Figueiredo, Carlos R.
Massaoka, Mariana H.
Farias, Camyla F.
Tada, Dayane B.
Maia, Vera C.
Silva Junior, Pedro I.
Girola, Natalia
Real, Fernando
Mortara, Renato A.
Polonelli, Luciano
Travassos, Luiz R.
AC‐1001 H3 CDR peptide induces apoptosis and signs of autophagy in vitro and exhibits antimetastatic activity in a syngeneic melanoma model
title AC‐1001 H3 CDR peptide induces apoptosis and signs of autophagy in vitro and exhibits antimetastatic activity in a syngeneic melanoma model
title_full AC‐1001 H3 CDR peptide induces apoptosis and signs of autophagy in vitro and exhibits antimetastatic activity in a syngeneic melanoma model
title_fullStr AC‐1001 H3 CDR peptide induces apoptosis and signs of autophagy in vitro and exhibits antimetastatic activity in a syngeneic melanoma model
title_full_unstemmed AC‐1001 H3 CDR peptide induces apoptosis and signs of autophagy in vitro and exhibits antimetastatic activity in a syngeneic melanoma model
title_short AC‐1001 H3 CDR peptide induces apoptosis and signs of autophagy in vitro and exhibits antimetastatic activity in a syngeneic melanoma model
title_sort ac‐1001 h3 cdr peptide induces apoptosis and signs of autophagy in vitro and exhibits antimetastatic activity in a syngeneic melanoma model
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011487/
https://www.ncbi.nlm.nih.gov/pubmed/27642552
http://dx.doi.org/10.1002/2211-5463.12080
work_keys_str_mv AT rabacaalinen ac1001h3cdrpeptideinducesapoptosisandsignsofautophagyinvitroandexhibitsantimetastaticactivityinasyngeneicmelanomamodel
AT arrudadenisec ac1001h3cdrpeptideinducesapoptosisandsignsofautophagyinvitroandexhibitsantimetastaticactivityinasyngeneicmelanomamodel
AT figueiredocarlosr ac1001h3cdrpeptideinducesapoptosisandsignsofautophagyinvitroandexhibitsantimetastaticactivityinasyngeneicmelanomamodel
AT massaokamarianah ac1001h3cdrpeptideinducesapoptosisandsignsofautophagyinvitroandexhibitsantimetastaticactivityinasyngeneicmelanomamodel
AT fariascamylaf ac1001h3cdrpeptideinducesapoptosisandsignsofautophagyinvitroandexhibitsantimetastaticactivityinasyngeneicmelanomamodel
AT tadadayaneb ac1001h3cdrpeptideinducesapoptosisandsignsofautophagyinvitroandexhibitsantimetastaticactivityinasyngeneicmelanomamodel
AT maiaverac ac1001h3cdrpeptideinducesapoptosisandsignsofautophagyinvitroandexhibitsantimetastaticactivityinasyngeneicmelanomamodel
AT silvajuniorpedroi ac1001h3cdrpeptideinducesapoptosisandsignsofautophagyinvitroandexhibitsantimetastaticactivityinasyngeneicmelanomamodel
AT girolanatalia ac1001h3cdrpeptideinducesapoptosisandsignsofautophagyinvitroandexhibitsantimetastaticactivityinasyngeneicmelanomamodel
AT realfernando ac1001h3cdrpeptideinducesapoptosisandsignsofautophagyinvitroandexhibitsantimetastaticactivityinasyngeneicmelanomamodel
AT mortararenatoa ac1001h3cdrpeptideinducesapoptosisandsignsofautophagyinvitroandexhibitsantimetastaticactivityinasyngeneicmelanomamodel
AT polonelliluciano ac1001h3cdrpeptideinducesapoptosisandsignsofautophagyinvitroandexhibitsantimetastaticactivityinasyngeneicmelanomamodel
AT travassosluizr ac1001h3cdrpeptideinducesapoptosisandsignsofautophagyinvitroandexhibitsantimetastaticactivityinasyngeneicmelanomamodel